Eris Lifesciences Investor Relations Material
Latest events
Q4 24/25
Eris Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Eris Lifesciences Limited
Access all reports
Eris Lifesciences Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations. The company focuses on therapeutic areas such as cardiovascular, diabetes, neurology, gastroenterology, and dermatology. It primarily caters to the domestic market, targeting healthcare professionals and patients through its portfolio of prescription medicines. The company is headquartered in Ahmedabad, India, and its shares are listed on the NSE and BSE.
Key slides for Eris Lifesciences Limited
Q3 24/25
Eris Lifesciences Limited
Q4 24/25
Eris Lifesciences Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ERIS
Country
🇮🇳 India